222

HIGHTIDE THERAPEUTICS INC.

No trades
See on Supercharts
Market capitalization
‪2.50 B‬HKD
−15.46HKD
‪−1.04 B‬HKD
‪227.80 M‬
Beta (1Y)
0.70

About HIGHTIDE THERAPEUTICS INC.

CEO
Liping Liu
Headquarters
Shenzhen
Employees (FY)
66
Founded
2011
FIGI
BBG01KK3SJW8
Hightide Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in the discovery and development of therapeutics for people suffering from non-viral chronic liver diseases, gastrointestinal diseases and metabolic disorders with large and unsatisfied market needs. The company was founded by Liping Liu in 2011 and is headquartered in Shenzhen, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 2511 is 4.86 HKD — it has decreased by 2.99% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange HIGHTIDE THERAPEUTICS INC. stocks are traded under the ticker 2511.
2511 stock is 7.82% volatile and has beta coefficient of 0.70. Check out the list of the most volatile stocks — is HIGHTIDE THERAPEUTICS INC. there?
Yes, you can track HIGHTIDE THERAPEUTICS INC. financials in yearly and quarterly reports right on TradingView.
2511 stock has risen by 2.32% compared to the previous week, the month change is a 14.44% fall, over the last year HIGHTIDE THERAPEUTICS INC. has showed a 59.23% decrease.
2511 net income for the last quarter is ‪−420.86 M‬ HKD, while the quarter before that showed ‪−621.73 M‬ HKD of net income which accounts for 32.31% change. Track more HIGHTIDE THERAPEUTICS INC. financial stats to get the full picture.
No, 2511 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2511 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HIGHTIDE THERAPEUTICS INC. stock right from TradingView charts — choose your broker and connect to your account.
2511 reached its all-time high on Jan 2, 2024 with the price of 13.18 HKD, and its all-time low was 4.00 HKD and was reached on Apr 12, 2024.
See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has 66.00 employees. See our rating of the largest employees — is HIGHTIDE THERAPEUTICS INC. on this list?
We've gathered analysts' opinions on HIGHTIDE THERAPEUTICS INC. future price: according to them, 2511 price has a max estimate of 17.01 HKD and a min estimate of 17.01 HKD. Read a more detailed HIGHTIDE THERAPEUTICS INC. forecast: see what analysts think of HIGHTIDE THERAPEUTICS INC. and suggest that you do with its stocks.